PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension
Studying Drug- or toxin-induced pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- University of Giessen
- Enrollment
- 40000 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2055
Study locations (1)
- University Giessen PH Center, Giessen, Hesse, Germany
Collaborators
Imperial College London · Johns Hopkins University · Stanford University · University of Sheffield · University of Pittsburgh · University of Pavia · Hospital de Niños de la Santísima Trinidad · Academy of Medical Sciences of Ukraine · The Methodist Hospital Research Institute · Vanderbilt University Medical Center · Mayo Clinic · National and Kapodistrian University of Athens · Aristotle University Of Thessaloniki · University Hospital of Targu Mures, Romania · University Hospital Heidelberg · Milpark Hospital · University of Minnesota · Royal Prince Alfred Hospital, Sydney, Australia · Fiona Stanley Hospital · Sunshine Coast University Hospital · China-Japan Friendship Hospital · Medical University of Graz · National Hospital Organization Okayama Medical Center · Royal Hobart Hospital · University Hospital, Zürich · Universidad Nacional de La Plata · Gold Coast Hospital and Health Service
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05329714 on ClinicalTrials.govOther trials for Drug- or toxin-induced pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07365332An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)Inhibikase Therapeutics
- RECRUITINGNANCT07529821Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Treadmill Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Pre-hypertensive PatientsFoundation University Islamabad
- ACTIVE NOT RECRUITINGNCT07312227A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in BoliviaMassachusetts General Hospital
- ENROLLING BY INVITATIONNANCT07558460Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled TrialIstanbul University - Cerrahpasa
- RECRUITINGPHASE2NCT07318597Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)Regeneron Pharmaceuticals
- RECRUITINGNANCT07366879Exercise Intervention as an Adjunct to Medical Therapy in Newly Diagnosed Patients With Pulmonary Arterial HypertensionGolden Jubilee National Hospital
- RECRUITINGPHASE3NCT07245680COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular ComorbiditiesAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE1NCT06872112A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial HypertensionJoseph C. Wu
See all trials for Drug- or toxin-induced pulmonary arterial hypertension →